Overview

Citalopram for Agitation in Alzheimer's Disease

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of citalopram for agitation in Alzheimer's dementia.
Phase:
Phase 3
Details
Lead Sponsor:
JHSPH Center for Clinical Trials
Collaborators:
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
Treatments:
Citalopram
Dexetimide